Cardiovascular disease

Use of digital patient decision-support tools for atrial fibrillation treatments: a systematic review and meta-analysis – Aileen Zeng et al.

2024-07-30T12:15:28+10:00Cardiac arrhythmia, Cardiovascular disease, Decision aids, Publications, Shared decision making, Treatment|

Atrial fibrillation (AF) is the most common cardiac arrhythmia and a key risk factor for embolic stroke and heart failure, with an increasing global burden as the population continues to age. AF treatment involves stroke prevention, symptom management, and cardiovascular and comorbidity optimisation. Treatment decisions [...]

Improving how we determine who should take blood pressure and lipid-lowering medications – Jenny Doust

2024-07-30T11:37:55+10:00Cardiovascular disease, Clinical guidelines, Hypertension, Publications, Risk, Treatment|

Cardiovascular disease (CVD) risk equations are useful to guide treatment decisions for blood pressure and lipid-lowering medications because they identify patients who are at high risk of CVD but do not have either blood pressure or cholesterol measurements above the levels when considering treatment as [...]

Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial – Prajith Jeyaprakash et al.

2024-07-30T10:39:40+10:00Cardiovascular disease, Imaging, Publications, Randomised Control Trial (RCT), Treatment|

This study aims to evaluate the efficacy and cost-effectiveness of sonothrombolysis delivered pre and post primary percutaneous coronary intervention (pPCI) on infarct size assessed by cardiac MRI, in patients presenting with STEMI, when compared against sham procedure. More than a half of patients with successful [...]

Eliminate all risks: A call to reexamine the link between canine scabies and rheumatic heart disease – Victoria J. Brookes et al.

2024-06-12T17:46:43+10:00Cardiovascular disease, One Health, Publications, Risk|

Rheumatic heart disease (RHD) and acute rheumatic fever (ARF) disproportionately affect individuals in low-resource settings. ARF is attributed to an immune response to Group A Streptococcus (GAS) following GAS pharyngitis and potentially GAS impetigo in which infection can be initiated by scabies infestation. The burden of ARF [...]

A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline – Renuka Shanmugalingam et al.

2024-06-05T15:54:34+10:00Cardiovascular disease, Clinical guidelines, Hypertension, Pregnancy, Publications, Risk, Screening, Women's health|

Hypertensive disorders of pregnancy (HDP) affect up to 10% of all pregnancies annually and are associated with an increased risk of maternal and fetal morbidity and mortality. This guideline represents an update of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) guidelines for [...]

How do general practitioners manage patient health literacy differences in cardiovascular disease prevention consultations? An interview study – Shannon McKinn et al.

2024-06-04T12:24:39+10:00Cardiovascular disease, General Practice, Health literacy, Prescribing, Primary Care, Publications, Treatment|

Low health literacy is associated with worse health outcomes, including for cardiovascular disease (CVD). However, general practitioners (GPs) have limited support to identify and address patient health literacy needs in CVD prevention consultations. This study explored GPs’ experiences of patient health literacy needs during CVD [...]

Aspirin as Venous Thromboembolism Prophylaxis in Arthroplasty Patients: An Analysis of Clinical Practice Guidelines Recommendations – Kimberley K. Lun et al.

2024-06-04T12:16:58+10:00Cardiovascular disease, Clinical guidelines, Hip, Knee, Musculoskeletal, Publications, Surgery|

Venous thromboembolism (VTE) is a recognized postoperative complication of hip or knee arthroplasty and incurs major morbidity and mortality. While anticoagulants are the mainstay of chemoprophylaxis, aspirin has recently emerged as a popular prophylactic agent. However, there is a lack of high-quality evidence comparing aspirin [...]

Prevention Works Podcast – How health literacy can combat misinformation and improve health for all

2024-05-31T12:53:48+10:00Cardiovascular disease, COVID-19, Health literacy, News|

The Prevention Centre featured the work of A/Prof Carissa Bonner and PhD Researcher Melody Taba on their podcast Prevention Works. Listen to Carissa and Melody discuss health literacy codesign and partnership research across cardiovascular disease and COVID projects, including the role of social media in [...]

Could nudges reduce health literacy disparities in CVD prevention? An experiment using alternative messages for CVD risk assessment screening – Michael Anthony Fajardo et al.

2024-04-05T14:58:38+11:00Cardiovascular disease, General Practice, Health literacy, Publications, Risk, Screening|

This study aimed to test different SMS messages inviting patients for a Heart Health Check with their GP. We also assessed how health literacy moderated these effects, to inform an Australian CVD risk screening program. Specifically, we tested a control message used in a previous [...]

First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data – Lin Zhu et al.

2024-04-05T14:44:05+11:00Ageing, Cardiovascular disease, Publications, Risk, Surgery|

Our population-based analysis of linked administrative data found that the annual number of first insertions of ICDs steadily increased in NSW during 2005–2016. Most ICD recipients were men, especially in older age groups, and the rise in annual number was most marked for men aged [...]

Go to Top